| Kathryn Y Groner, | |
|
4755 Ogletown Stanton Rd, Newark, DE 19718-0001 | |
| (302) 733-1042 | |
| Not Available |
| Full Name | Kathryn Y Groner |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 14 Years |
| Location | 4755 Ogletown Stanton Rd, Newark, Delaware |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346560687 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | C10010331 (Delaware) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Christiana Hospital | Newark, DE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Doctors For Emergency Service | 0648160341 | 32 |
News Archive
The chronic side-effects of radiotherapy for early breast cancer, as reported by women themselves, are not any worse when treatment is given in a lower overall dose in fewer but larger treatments according to a trial part funded by Cancer Research UK and published today in the Lancet Oncology.
The American Brain Tumor Association (ABTA) has announced that Ryan Salinas, now a 2nd-year medical student at the University of California, San Francisco (UCSF), is the 2010 Lucien Rubenstein Award recipient. The work of Salinas, one of 10 ABTA Medical Student Summer Fellows in 2010, was deemed "outstanding" by the organization's distinguished Scientific Advisory Council.
ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for cardiovascular diseases, today announced that the U.S. Patent and Trademark Office has issued a patent on methods for determining whether to administer or prescribe bucindolol to a patient based on whether the patient has a specific genotype - homozygous for the arginine 389 polymorphism in the beta-1 adrenergic receptor.
The global peripheral vascular devices market is forecast to increase from $4.3 billion in 2010 to $5.3 billion by 2017, according to a new report available on companiesandmarkets.com.
"Over the last two weeks, a series of meetings were held in Amsterdam in the Netherlands - advocates and people from the communities affected by HIV/AIDS, tuberculosis [TB] and malaria came together to strategize and decide on courses of action to take in this critical year of replenishing the Global Fund to Fight AIDS, Tuberculosis and Malaria," Lucy Chesire, executive director and secretary to the board of the TB ACTION Group, writes in the Huffington Post's "Impact" blog.
› Verified 4 days ago
| Entity Name | Doctors For Emergency Service |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750369674 PECOS PAC ID: 0648160341 Enrollment ID: O20210625000768 |
News Archive
The chronic side-effects of radiotherapy for early breast cancer, as reported by women themselves, are not any worse when treatment is given in a lower overall dose in fewer but larger treatments according to a trial part funded by Cancer Research UK and published today in the Lancet Oncology.
The American Brain Tumor Association (ABTA) has announced that Ryan Salinas, now a 2nd-year medical student at the University of California, San Francisco (UCSF), is the 2010 Lucien Rubenstein Award recipient. The work of Salinas, one of 10 ABTA Medical Student Summer Fellows in 2010, was deemed "outstanding" by the organization's distinguished Scientific Advisory Council.
ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for cardiovascular diseases, today announced that the U.S. Patent and Trademark Office has issued a patent on methods for determining whether to administer or prescribe bucindolol to a patient based on whether the patient has a specific genotype - homozygous for the arginine 389 polymorphism in the beta-1 adrenergic receptor.
The global peripheral vascular devices market is forecast to increase from $4.3 billion in 2010 to $5.3 billion by 2017, according to a new report available on companiesandmarkets.com.
"Over the last two weeks, a series of meetings were held in Amsterdam in the Netherlands - advocates and people from the communities affected by HIV/AIDS, tuberculosis [TB] and malaria came together to strategize and decide on courses of action to take in this critical year of replenishing the Global Fund to Fight AIDS, Tuberculosis and Malaria," Lucy Chesire, executive director and secretary to the board of the TB ACTION Group, writes in the Huffington Post's "Impact" blog.
› Verified 4 days ago
| Entity Name | Christiana Care Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871375899 PECOS PAC ID: 8022468057 Enrollment ID: O20240103001008 |
News Archive
The chronic side-effects of radiotherapy for early breast cancer, as reported by women themselves, are not any worse when treatment is given in a lower overall dose in fewer but larger treatments according to a trial part funded by Cancer Research UK and published today in the Lancet Oncology.
The American Brain Tumor Association (ABTA) has announced that Ryan Salinas, now a 2nd-year medical student at the University of California, San Francisco (UCSF), is the 2010 Lucien Rubenstein Award recipient. The work of Salinas, one of 10 ABTA Medical Student Summer Fellows in 2010, was deemed "outstanding" by the organization's distinguished Scientific Advisory Council.
ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for cardiovascular diseases, today announced that the U.S. Patent and Trademark Office has issued a patent on methods for determining whether to administer or prescribe bucindolol to a patient based on whether the patient has a specific genotype - homozygous for the arginine 389 polymorphism in the beta-1 adrenergic receptor.
The global peripheral vascular devices market is forecast to increase from $4.3 billion in 2010 to $5.3 billion by 2017, according to a new report available on companiesandmarkets.com.
"Over the last two weeks, a series of meetings were held in Amsterdam in the Netherlands - advocates and people from the communities affected by HIV/AIDS, tuberculosis [TB] and malaria came together to strategize and decide on courses of action to take in this critical year of replenishing the Global Fund to Fight AIDS, Tuberculosis and Malaria," Lucy Chesire, executive director and secretary to the board of the TB ACTION Group, writes in the Huffington Post's "Impact" blog.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kathryn Y Groner, 426 Harvard Ave, Apt 3a, Swarthmore, PA 19081-1711 Ph: (610) 909-5893 | Kathryn Y Groner, 4755 Ogletown Stanton Rd, Newark, DE 19718-0001 Ph: (302) 733-1042 |
News Archive
The chronic side-effects of radiotherapy for early breast cancer, as reported by women themselves, are not any worse when treatment is given in a lower overall dose in fewer but larger treatments according to a trial part funded by Cancer Research UK and published today in the Lancet Oncology.
The American Brain Tumor Association (ABTA) has announced that Ryan Salinas, now a 2nd-year medical student at the University of California, San Francisco (UCSF), is the 2010 Lucien Rubenstein Award recipient. The work of Salinas, one of 10 ABTA Medical Student Summer Fellows in 2010, was deemed "outstanding" by the organization's distinguished Scientific Advisory Council.
ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for cardiovascular diseases, today announced that the U.S. Patent and Trademark Office has issued a patent on methods for determining whether to administer or prescribe bucindolol to a patient based on whether the patient has a specific genotype - homozygous for the arginine 389 polymorphism in the beta-1 adrenergic receptor.
The global peripheral vascular devices market is forecast to increase from $4.3 billion in 2010 to $5.3 billion by 2017, according to a new report available on companiesandmarkets.com.
"Over the last two weeks, a series of meetings were held in Amsterdam in the Netherlands - advocates and people from the communities affected by HIV/AIDS, tuberculosis [TB] and malaria came together to strategize and decide on courses of action to take in this critical year of replenishing the Global Fund to Fight AIDS, Tuberculosis and Malaria," Lucy Chesire, executive director and secretary to the board of the TB ACTION Group, writes in the Huffington Post's "Impact" blog.
› Verified 4 days ago
Dr. Sepehr Sedigh Haghighat, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogletown Stanton Rd, Newark, DE 19718 Phone: 302-733-3901 | |
Paul C Anderson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogeltown Stanton Road, Newark, DE 19718 Phone: 302-733-1000 Fax: 302-733-1633 | |
Valerie Ann Cohen, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogletown Stanton Rd, Newark, DE 19718 Phone: 302-623-4050 | |
Brian E Burgess, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogletown Stanton Road, Newark, DE 19718 Phone: 302-733-1000 Fax: 302-733-1633 | |
Kristina Louise Stransky, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogletown Stanton Rd, Newark, DE 19718 Phone: 302-733-1042 | |
Dr. John Thomas Powell, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: Christiana Hospital Academic Affairs, Suite 2a00, Newark, DE 19718 Phone: 302-733-1557 | |
Dr. Jennifer Terrano Mink, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogletown Stanton Rd, Christiana Hospital C/o Emergency Medicine Suite 1071, Newark, DE 19718 Phone: 302-733-1840 Fax: 302-733-1633 |